Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.
The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research.
Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study.
Development of cladribine at Scripps for hairy cell leukemia and current results.
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.
Genmab announces results of ofatumumab Phase II study in multiple sclerosis
Complex antibody profiling to predict clinical outcome in childhood ADS.
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
Spectrum of nontraumatic myelopathies in Ethiopian patients: hospital-based retrospective study.
Immunological mechanisms underlying delayed-type hypersensitivity reactions to glatiramer acetate.
Multiple sclerosis: risk factors, prodromes, and potential causal pathways.
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).
Chronic cladribine administration increases amyloid Beta Peptide generation and plaque burden in mice.
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
GeNeuro Successful Phase 2a Clinical Study Reinforces Novel Approach to Treat Multiple Sclerosis: Patients Receiving First in Class GNbAC1 Mab Are Stable After One Year
A G protein-coupled receptor is essential for Schwann cells to initiate myelination.
Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases.
Antigen-specific tolerance by autologous myelin Peptide-coupled cells: a phase 1 trial in multiple sclerosis.
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.
Inflammatory cortical demyelination in early multiple sclerosis.
Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years.
Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis.
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis.

Pages